17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 4.01<br />

Grading of type I (endometrioid and mucinous)<br />

endometrial adeno<strong>carcinoma</strong>.<br />

– Grade 1: ≤ 5% non-squamous, non-morular<br />

growth pattern<br />

– Grade 2: 6-50% non-squamous, non-morular<br />

growth pattern<br />

– Grade 3: > 50% non-squamous, non-morular<br />

growth pattern<br />

Note: Squamous/morular components are<br />

excluded from grading. Bizarre nuclear atypia<br />

should raise the grade by one (i.e. from 1 to 2 or<br />

2 to 3) but may also signify type II differentiation.<br />

noma or may coexist with the usual<br />

endometrioid pattern within a single<br />

tumour.<br />

Ciliated cell variant<br />

Although occasional ciliated cells may<br />

be seen in many endometrioid adeno<strong>carcinoma</strong>s,<br />

the diagnosis of the ciliated cell<br />

variant is made only when ciliated cells<br />

line the majority of the malignant glands.<br />

Defined in this manner, this is a rare variant,<br />

and the glands often have a strong<br />

resemblance to tubal epithelium.<br />

Mucinous adeno<strong>carcinoma</strong><br />

Definition<br />

A primary adeno<strong>carcinoma</strong> of the<br />

endometrium in which most of the tumour<br />

cells contain prominent intracytoplasmic<br />

mucin.<br />

Epidemiology<br />

Mucinous adeno<strong>carcinoma</strong> comprises<br />

up to 9% of all cases of surgical stage I<br />

endometrial <strong>carcinoma</strong> {2454}. However,<br />

in most published series it is a relatively<br />

r a re type of endometrial carc i n o m a<br />

{1842}.<br />

Histopathology<br />

Both endometrioid and clear cell adeno<strong>carcinoma</strong>s<br />

may have large amounts of<br />

intraluminal mucin, but only mucinous<br />

a d e n o c a rcinoma contains the mucin<br />

within the cytoplasm. The mucin is usually<br />

easily visible with hematoxylin and<br />

eosin staining but may also be demonstrated<br />

with a mucicarmine or other<br />

mucin stain.<br />

Variants<br />

Some mucinous adeno<strong>carcinoma</strong>s have<br />

a microglandular pattern and may be difficult<br />

to distinguish from microglandular<br />

hyperplasia of the endocervix in a biopsy<br />

specimen {2066}. These neoplasms<br />

have been reported as microglandular<br />

<strong>carcinoma</strong>s {3224,3241}. Rare mucinous<br />

a d e n o c a rcinomas of the endometrium<br />

may show intestinal differentiation, containing<br />

numerous goblet cells.<br />

Differential diagnosis<br />

The main differential diagnosis of the<br />

usual endometrial mucinous adeno<strong>carcinoma</strong><br />

is with a primary mucinous adeno<strong>carcinoma</strong><br />

of the endocervix. The distinction<br />

may be particularly difficult in a<br />

biopsy or curettage specimen but is crucial<br />

for therapy and may have to be<br />

resolved by clinical and imaging studies.<br />

Some studies have claimed that immunohistochemistry<br />

is useful in determining<br />

the site of origin of an adeno<strong>carcinoma</strong> in<br />

such a specimen, with endometrial <strong>carcinoma</strong>s<br />

being vimentin and estro g e n<br />

receptor-positive and carcinoembryonic<br />

antigen-negative and the opposite findings<br />

for endocervical adeno<strong>carcinoma</strong>s<br />

{3180}. Others have found, however, that<br />

this distinction is based more on differentiation<br />

(endometrioid vs. mucinous) than<br />

on site of origin {1393}.<br />

Fig. 4.05 Well differentiated endometrioid adeno<strong>carcinoma</strong>,<br />

villoglandular variant. Villous fronds<br />

have delicate central cores and are lined by cells<br />

with stratified nuclei.<br />

Grading<br />

Mucinous adeno<strong>carcinoma</strong>s are theoretically<br />

graded in the same way as<br />

endometrioid adeno<strong>carcinoma</strong>s, but in<br />

practice almost all of them are grade 1.<br />

Prognosis and predictive factors<br />

The prognosis appears to be similar to<br />

that of other low grade endometrial aden<br />

o c a rcinomas and thus is generally<br />

favourable.<br />

Serous adeno<strong>carcinoma</strong><br />

Definition and historical annotation<br />

A primary adeno<strong>carcinoma</strong> of the<br />

endometrium characterized by a complex<br />

pattern of papillae with cellular budding<br />

and not infrequently containing<br />

psammoma bodies.<br />

Although long recognized as a common<br />

type of adeno<strong>carcinoma</strong> of the ovary,<br />

serous adeno<strong>carcinoma</strong> was first characterized<br />

as a common endometrial<br />

tumour in the early 1980s {1186,1590}.<br />

Clinical features<br />

Serous <strong>carcinoma</strong> typifies the so-called<br />

type II endometrial <strong>carcinoma</strong>, which dif-<br />

Fig. 4.06 Mucinous adeno<strong>carcinoma</strong> of the<br />

endometrium. All of the tumour cells in this field<br />

contain voluminous intracytoplasmic mucin.<br />

Fig. 4.07 Microglandular <strong>carcinoma</strong>. Atypia, mitoses<br />

and the endometrial location distinguish this tumour<br />

from endocervical microglandular hyperplasia.<br />

Fig. 4.08 Mucinous metaplasia. Mucinous glands<br />

are prominent, however, glandular crowding or<br />

atypia is not present.<br />

224 Tumours of the uterine corpus

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!